HDFC Securities downgrades Eris to Add from Buy, as the strong run-up in the stock price factors in near-term triggers.

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Insulin pumps are small, wearable devices that deliver rapid-acting insulin for people with diabetes. Learn how they work, their benefits, their drawbacks, and more.

Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using ...

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

maker Becton, Dickinson and Company Location Currently not on view date made ca 2000 ID Number 2002.0098.10 accession number 2002.0098 catalog number 2002.0098.10 Object Name insulin delivery device ...

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the U.S. company is using 'deceptive marketing' to sell copycat versions of its obesity ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

More specifically, the law authorizes this in group home facilities, permitting the use of sliding-scale insulin therapy, insulin pens, and epinephrine via an insulin pen.

Access to diabetes care in lower-income countries still lags for children, despite efforts from insulin makers.

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to American rival ...

Novo launched the NovoPen - the first insulin pen device in 1985. 2000–2017 Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business.